PraxisPro raises $6M seed from AlleyCorp to coach medical sales reps

The roots of PraxisPro trace back to a career in sales. Cam Badger began his professional journey at a pharmaceutical company, expecting to encounter transparent processes, structured mentorship, and strong on-the-job guidance. Instead, he found what he described to TechCrunch as “fragmented training, inconsistent coaching, and no real way to scale learning in a meaningful way.”

Badger spent four years working first as a sales representative and later as a sales trainer before joining a medical startup, where he met Dr Benny Alouf. Together, they frequently discussed how ineffective many sales representatives were across life sciences companies, including pharmaceutical firms and medical device startups. Along with Bhrugu Giri, the group decided to tackle the problem head-on by launching PraxisPro, a sales coaching platform built specifically for the medical and life sciences fields.

Badger believes that improving the quality of sales professionals can directly influence patient outcomes by helping effective treatments reach physicians more efficiently, ultimately benefiting the people who need those therapies.

“When commercial interactions with healthcare providers are ineffective, patients don’t get a fair shot at therapies that could meaningfully change their lives,” said Badger, who serves as the company’s chief executive.

PraxisPro was founded in 2023, although its first product did not reach the market until 2025. On Wednesday, the company announced that it had raised a $6 million seed round led by AlleyCorp. Additional investors participating in the round include Flybridge, South Loop Ventures, and Zeal Capital Partners.

The platform operates as a standalone product while also offering integration with existing enterprise software systems. PraxisPro builds small language models trained on proprietary life sciences data, enabling organisations to better understand the regulatory nuances and contextual challenges involved in engaging with healthcare providers. On top of this foundation, the company has developed an AI-powered agent that allows commercial sales teams to rehearse and refine their messaging before interacting with customers.

According to Badger, communication plays a particularly critical role in medical sales. Many commercial teams are highly focused on compliance, since companies are responsible for ensuring that all sales messaging aligns with legal and regulatory requirements. In addition to helping representatives stay compliant, PraxisPro aims to improve how effectively sales reps communicate patient needs and clinical value to healthcare professionals.

In a typical sales cycle, a representative may interact with a healthcare provider as many as 15 times. PraxisPro offers a conversational AI tool that lets sales reps simulate and plan for these discussions in advance, helping them prepare for common questions, objections, and potential resistance that may arise during real-world conversations.

While other AI-driven role-playing platforms exist — including tools such as Quantified and SmartWinnr — Badger says PraxisPro stands apart because it is trained on smaller, more specialised datasets and is narrowly focused on the life sciences sector. He noted that the newly raised capital will primarily be allocated toward further research and development.

In many respects, PraxisPro represents the solution Badger wishes had existed earlier in his career. He recalled struggling significantly during his early days in sales and nearly losing his job before eventually working his way up to become one of his employer’s top-performing representatives. Now, he wants to make that journey easier for others.

“If we can give commercial teams the ability to prepare, practice, and engage at a higher level, consistently and responsibly, then we’re not just improving commercial operations,” Badger said. “We’re helping ensure that innovative therapies reach the patients who need them most.”